STOCK TITAN

Nexgel Inc Stock Price, News & Analysis

NXGL Nasdaq

Welcome to our dedicated page for Nexgel news (Ticker: NXGL), a resource for investors and traders seeking the latest updates and insights on Nexgel stock.

NEXGEL, Inc. (NASDAQ: NXGL) generates news across healthcare, consumer products, and capital markets through developments tied to its ultra-gentle, high-water-content hydrogel technology. The company regularly issues press releases on quarterly financial results, highlighting performance in its contract manufacturing segment and its portfolio of consumer-branded products in health, beauty, and OTC categories.

Investors following NXGL news will see updates on earnings announcements, including revenue trends, gross margin, operating expenses, and non-GAAP metrics such as EBITDA and Adjusted EBITDA. Management commentary often discusses demand for branded products, new contract manufacturing agreements, and the impact of partnerships with consumer healthcare companies.

NEXGEL’s news flow also covers strategic and corporate actions. Recent items include the spin-off of select drug delivery application assets into NexGelRx, with NEXGEL retaining a royalty interest, an equity stake, and exclusive hydrogel manufacturing rights. Additional releases have described expanded partnerships, such as the agreement with STADA Arzneimittel AG involving non-dilutive capital to support product launches and marketing efforts, as well as financing transactions like registered direct offerings and concurrent private placements.

Governance and leadership developments are another recurring news theme. NEXGEL has announced board appointments, conference presentations at investor events, and changes in senior finance roles through its press releases and associated SEC filings. Readers of this NXGL news page can review these updates in one place, including information on special meetings of stockholders, strategic advisors to NexGelRx, and other events that shape the company’s direction.

By monitoring the NXGL news feed, market participants can track how NEXGEL’s hydrogel-focused business, partnerships, financings, and governance decisions evolve over time, using official company communications as a primary source.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.91%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.36%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
partnership
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags

FAQ

What is the current stock price of Nexgel (NXGL)?

The current stock price of Nexgel (NXGL) is $1.11 as of February 25, 2026.

What is the market cap of Nexgel (NXGL)?

The market cap of Nexgel (NXGL) is approximately 9.6M.

NXGL Rankings

NXGL Stock Data

9.61M
6.90M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE

NXGL RSS Feed